$1.74
0.0372.18%
Last update: Dec 16, 9:53 AM
Comments
Loading...
TherapeuticsMD Analyst Ratings and Price Targets | NASDAQ:TXMD | Benzinga
TherapeuticsMD Inc has a consensus price target of $5 based on the ratings of 1 analysts. The high is $5 issued by Cantor Fitzgerald on August 17, 2023. The low is $5 issued by Cantor Fitzgerald on August 17, 2023. The 2 most-recent analyst ratings were released by Cantor Fitzgerald on August 17, 2023 and January 11, 2023, respectively. With an average price target of $5 between Cantor Fitzgerald, there's an implied 187.85% upside for TherapeuticsMD Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for TherapeuticsMD
FAQ
What is the target price for TherapeuticsMD (TXMD) stock?
The latest price target for TherapeuticsMD (NASDAQ:TXMD) was reported by Cantor Fitzgerald on August 17, 2023. The analyst firm set a price target for $5.00 expecting TXMD to rise to within 12 months (a possible 187.85% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TherapeuticsMD (TXMD)?
The latest analyst rating for TherapeuticsMD (NASDAQ:TXMD) was provided by Cantor Fitzgerald, and TherapeuticsMD reiterated their neutral rating.
When was the last upgrade for TherapeuticsMD (TXMD)?
There is no last upgrade for TherapeuticsMD
When was the last downgrade for TherapeuticsMD (TXMD)?
There is no last downgrade for TherapeuticsMD.
When is the next analyst rating going to be posted or updated for TherapeuticsMD (TXMD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TherapeuticsMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TherapeuticsMD was filed on August 17, 2023 so you should expect the next rating to be made available sometime around August 17, 2024.
Is the Analyst Rating TherapeuticsMD (TXMD) correct?
While ratings are subjective and will change, the latest TherapeuticsMD (TXMD) rating was a reiterated with a price target of $0.00 to $5.00. The current price TherapeuticsMD (TXMD) is trading at is $1.74, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
